Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022

02:04pm, Thursday, 07'th Jul 2022 Benzinga
Upgrades For Pacific Premier Bancorp Inc (NASDAQ:PPBI), Raymond James upgraded the previous rating of Outperform to Strong Buy. In the first quarter, Pacific Premier Bancorp showed an EPS of $0.70, co
Shares of Seagen Inc (NASDAQ: SGEN) are up 3.0% this morning on a report that Merck & Co Inc (NYSE: MRK) is in advanced talks to buy the cancer drug specialist for at least $40 billion. Dr Gottlieb re

Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?

01:00pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The chief economist and market strategist at MKM Partners says, historically, stocks rally after multiples sharply compress.

Seagen (SGEN) Stock Pops on Merck Buyout Rumors

11:58am, Thursday, 07'th Jul 2022
Seagen (SGEN) stock is getting a boost on Thursday as rumors circulate that Merck (MRK) is considering a buyout of the biotechnology company. The post Seagen (SGEN) Stock Pops on Merck Buyout Rumors a
Truist Securities cut Criteo S.A. (NASDAQ: CRTO) price target from $40 to $35. Criteo shares fell 3.5% to close at $22.92 on Wednesday. Barclays raised Eli Lilly and Company (NYSE: LLY) price targ
Pharma giant Merck is in advanced talks to acquire biotech Seagen in a deal valued at roughly $40 billion, according to a Wall Street Journal report.
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The drugmaker is defying the stock market sell-off right now.
Yahoo Finance Live anchors discuss reports of an acquisition deal between Merck and Seagen.

Why Merck Is Sending Seagen Stock Higher Today

09:25am, Thursday, 07'th Jul 2022
Seagen Inc (NASDAQ: SGEN) shares are trading higher Thursday following reports suggesting Merck & Company Inc (NYSE: MRK) is in advanced talks to acquire the company. According to a Wall Street Jou
Merck & Co Inc (NYSE: MRK) is in advanced talks to acquire Seagen Inc (NASDAQ: SGEN), and an agreement on a purchase is expected in the next few weeks, Wall Street Journal reported citing people
Merck & Co. is in advanced talks to acquire Seagen Inc. and is aiming to finalize a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal tha
Merck & Co is reportedly in talks to acquire biotech company Seagen Inc. in a nearly $40 billon deal that would add to the company's cancer drug portfolio.
Drugmaker Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly $40 billion or more, the Wall Street Journal reported on Wednesday.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE